期刊文献+

NAD延缓背根神经节轴突变性的实验研究 被引量:1

Nicotinamide adenine dinucleotide prevents axonal degeneration
原文传递
导出
摘要 目的探讨烟酰胺腺嘌呤二核苷酸(NAD)对神经轴突变性的保护作用。方法用长春新碱处理原代培养的背根神经节细胞,建立轴突变性细胞模型,然后加入不同浓度的NAD,观察神经轴突生长状况,MTT检测背根神经节细胞的生长活性,行神经丝蛋白(NF)免疫组化染色观察神经轴突的变化。结果损伤组加入长春新碱8 h后,轴突远端发生典型的轴突变性,12 h后轴突肿胀,断裂,24 h后见不到完整的轴突结构。保护组加入NAD后可明显延缓轴突变性,在12 h后仍能保持比较完整轴突结构,24 h后远端发生轻微变性。MTT结果显示:NAD保护组可提高细胞存活率(P<0.01)。轴突计数显示:NAD保护组在加入长春新碱后12 h,只有35%左右的轴突发生变性,而损伤组却高达60%的轴突发生了变性(P<0.01)。结论NAD对轴突变性具有明显的保护作用,可延缓轴突变性。 Objective To explore the effect of nicotinamide adenine dinucleotide (NAD) in delaying axonal degeneration. Methods Dorsal root ganglion(DRG) cells were isolated from neonate rats and cultured in DMEM/F12 medium, and then treated with vincrisfine to establish an axonal degeneration model. NAD of different concentrations was added in the culture medium to detect its protective effects. Mona] degeneration was identified by immunocytocheraical staining and by MqT analysis, and length and number of DRG cells were determined using the software IPP. Results DRG cells treated with vineristine suffered typical axonal degeneration in the distal end of the axon at 8h in vitro. The axon was swollen and disrupted at 12 h. There was no intact axonal structure after a 24 h-treatment with vincristine. The end of the axon had normal axonal structure at 12 h in culture, and the axon had light degeneration at 24 h in vitro culture. MTT analysis showed that the experimental groups containing NAD had higher cell survival rates than the injury groups. Axon counting showed that only 35% of axons degenerated in the experimental groups, while only 60% of axons degenerated in the injury groups. Conclusion NAD plays an important role in preventing axonal degeneration.
出处 《山东大学学报(医学版)》 CAS 北大核心 2009年第3期12-15,共4页 Journal of Shandong University:Health Sciences
基金 山东省自然科学基金资助课题(Y2007C003)
关键词 轴突 背根神经节 烟酰胺腺嘌呤二核苷酸 大鼠 WISTAR Axonal Dorsal mot ganglia Nicotinamide adenine dinucleotide Rat, Wistar
  • 相关文献

参考文献11

  • 1Raff M C, Whitmire A V, Finn J T. Axonal self-destruction and neurodegeration [ J ]. Science, 2002, 296 (5569): 868- 871.
  • 2Yang T L, Sauve A A . NAD metabolism and sirtuins: Metabolic regulation of protein deacetylation in stress and toxicity[J]. J AAPS, 2006, 8(4):632-643.
  • 3Bedalov A, Julian A. Simon NAD to the Rescue[J]. Science, 2004, 305 (5686) : 954-955.
  • 4Sasaki Y, Araki T, Milbrandt J. Stimulation of nicotinamide adenine dinucleotide biosynthetic pathways delays axonal degeneration after axotomy [ J ]. J Neurosurg Sci, 2006, 26 (33) : 8484-8491.
  • 5Wagstaff M J, Collaco2Momes Y, Smith J, et al. Protection of neuronal cells from apop tosis by Hsp27 delivered with a herpes sim2p lex virus2based vector [J]. J Biol Chem, 1999, 274 (8) : 5061-5069.
  • 6Suzuki K, Koike T. Mammalian Sir2-related protein (SIRT)2- mediated modulation of resistance to axonal degeneration in slow Wallerian degeneration mice: A crucial role of tubulin deacety- lation[J]. Neuroseienee, 2007, 147(3) :599-612.
  • 7Coleman M. Axon degeneration mechanisms: Commonality amid diversity[J]. Nat Rev Neurosci, 2005, 6(11):889-898.
  • 8Lunn E R, Perry V H, Brown M C. Absence of wallerian degeneration does not hinder regeneration in peripheral nerve[J]. Eur J Neurosci, 1989, 1(1 ) :27-33.
  • 9Ferri A, Sanes J R, Coleman M P. Inhibiting axon degeneration and synapse loss attenuates apoptosis and disease progression in a mouse model of motoneuron disease[J]. Curr Biol, 2003, 13(8) :669-673.
  • 10Araki T, Sasaki Y, Milbrandt J. Increased nuclera NAD biosynthesis and activation prevent axonal degeneration[ J]. Science, 2004, 305(5686) : 1010-1013.

同被引文献11

  • 1朱剑,刘超.Sirt1功能的研究进展[J].国际内分泌代谢杂志,2007,27(B04):1-3. 被引量:4
  • 2RaffM C, Whitmire A V, Firm J T. Axonal self-destruction and nettrodegeration[J]. Science, 2002, 296(5569):868-871.
  • 3Yang T L, Sauve A A. NAD metabolism and sirtuins : Metabolic regulation of protein deacetylation in stress and toxicity[J]. J AAPS, 2006, 8(4):632-643.
  • 4Frye R-A. Phylogenetic classification of prokaryotic and ukaryotic Sir2-1ike proteins[ J]. Biochem-3', Biophy Res Commu, 2000, 273(2) :793-798.
  • 5Blander G, Guarente L. The SIR2 family of pritein deacetylases [J]. Ann Revi-Biochem, 2004, 9(5):431-440.
  • 6Nayagam V M, Wang X, Tan Y C, et al. SIRT1 modulating compounds from high-throughput screening as anti-inflammatory and insulin-sensitizing agents[J]. J Biomole Screen, 2006, 11 (8) :959-967.
  • 7Sagot Y, Dubous-Dauphin M, Tan S A, et al. Bcl-2 overexpression prevents motoneuron cell body loss but not axonal degeneration in a mouse model of a neurodegenerative disease [J]. J Neurosci, 1995, 15(1):7727-7733.
  • 8Bogan K L, Bremler C. Nicotinic acid, nicotinamide, and nicotinamide riboside : a molecular evaluation of NAD + precursor vitamins in human nutrition [ J ]. Arm Rey Nutr, 2008, 28 (22) :115-130.
  • 9Qin w, Yang T, Ho L, et al. Neuronal SIRT1 activation as a novel mechanism underlying the prevention of alzheimer disease amyloid neuropathology by calorie restriction [ J ]. Biol Chem, 2006, 281(31 ) : 21745-21754.
  • 10Song M S, Saavedra L, de Chaves E I. Apoptosis is secondary to non-apoptotie axonal degeneration in neurons exposed to abeta in distal axons[J]. Neurobiol Aging, 2006, 27 (9) : 1224-1238.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部